Multi‐omics profiling of primary hepatic stellate cells from advanced liver fibrosis patients reveals distinctive molecular signatures
Journal of Gastroenterology and Hepatology · 2023
DOI: 10.1111/jgh.16221 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastroenterology and Hepatology, 2023. Verfasst von Yutong Dong und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatology, Center of Infectious Diseases and Pathogen Biology, The First Hospital of Jilin University, Changchun, China. Hauptthemen laut MEDLINE: Multiomics, Hepatic Stellate Cells. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Program of JLU Science and Technology Innovative Research Team.
Abstract (Originalsprache)
Background and Aim Hepatic fibrosis is a common pathogenic outcome of almost all chronic liver diseases and a growing public health problem globally. However, the key genes or proteins driving liver fibrosis and cirrhosis are not well understood. We aimed to identify novel hepatic fibrosis genes of human primary hepatic stellate cells (HSCs).
Methods
Human primary HSCs were isolated from surgically resected advanced fibrosis liver tissues ( n = 6) and surgical resection of normal liver tissue around hemangioma ( n = 5). Differences in the expression levels of mRNA and proteins from HSCs in advanced fibrosis group and the control group were analyzed using RNA sequencing and mass spectrometry as transcriptomic and proteomic approaches. The obtained biomarkers were further validated through real‐time quantitative polymerase chain reaction (RT‐qPCR), immunofluorescence, and Western blot.
Results
A total of 2156 transcripts and 711 proteins were found to be differently expressed between the advanced fibrosis group and the control group patients. The Venn diagram shows that a total of 96 upregulated molecules are overlapped in both the transcriptomic and proteomic datasets. Gene Ontology enrichment analysis and Kyoto Encyclopedia of Genes and Genomes analysis indicated that those overlapped genes were mainly involved in wound healing, cell adhesion regulation, and actin binding, which reflects the major biological conversions in liver cirrhosis process. Pyruvate kinase M2 and EH domain‐containing 2 were identified as potential new markers for advanced liver cirrhosis, which have been validated in primary human HSCs and in vitro cellular hepatic fibrosis model Lieming Xu‐2 (LX‐2) cells.
Conclusions
Our results revealed the major transcriptomic and proteomic changes during liver cirrhosis process and identified new biomarkers and potential therapeutic targets for advanced liver fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepatology, Center of Infectious Diseases and Pathogen Biology, The First Hospital of Jilin University, Changchun, China.
- Key Laboratory of Zoonosis Research, Ministry of Education, Jilin University, Changchun, China.
- Department of Hepatobiliary and Pancreatic Surgery, General Surgery Center, The First Hospital of Jilin University, Changchun, China.
Förderung
- Program of JLU Science and Technology Innovative Research Team
Zitieren
APA
Dong, Y., Liu, Y., Liu, X., Ma, H., Liu, Y., Lv, G., & Niu, J. (2023). Multi‐omics profiling of primary hepatic stellate cells from advanced liver fibrosis patients reveals distinctive molecular signatures. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.16221
Vancouver
Dong Y, Liu Y, Liu X, Ma H, Liu Y, Lv G, et al. Multi‐omics profiling of primary hepatic stellate cells from advanced liver fibrosis patients reveals distinctive molecular signatures. Journal of Gastroenterology and Hepatology. 2023. doi:10.1111/jgh.16221
BibTeX
@article{Dong2023,
author = {Dong, Yutong and Liu, Yuwei and Liu, Xu and Ma, Heming and Liu, Yahui and Lv, Guoyue and Niu, Junqi},
title = {Multi‐omics profiling of primary hepatic stellate cells from advanced liver fibrosis patients reveals distinctive molecular signatures},
journal = {Journal of Gastroenterology and Hepatology},
year = {2023},
doi = {10.1111/jgh.16221}
}
EUVIMED